-Decrease of AMPK-related signal transduction and insufficient lipid oxidation contributes to the pathogenesis of obesity and type 2 diabetes. Previously, we identified that diacylglycerol kinase-␦ (DGK␦), an enzyme involved in triglyceride biosynthesis, is reduced in skeletal muscle from type 2 diabetic patients. Here, we tested the hypothesis that DGK␦ plays a role in maintaining appropriate AMPK action in skeletal muscle and energetic aspects of contraction. Voluntary running activity was reduced in DGK␦ ϩ/Ϫ mice, but glycogen content and mitochondrial markers were unaltered, suggesting that DGK␦ deficiency affects skeletal muscle energetics but not mitochondrial protein abundance. We next determined the role of DGK␦ in AMPK-related signal transduction and lipid metabolism in isolated skeletal muscle. AMPK activation and signaling were reduced in DGK␦ ϩ/Ϫ mice, concomitant with impaired lipid oxidation and elevated incorporation of free fatty acids into triglycerides. Strikingly, DGK␦ deficiency impaired work performance, as evident by altered force production and relaxation dynamics in response to repeated contractions. In conclusion, DGK␦ deficiency impairs AMPK signaling and lipid metabolism, thereby highlighting the deleterious role of excessive lipid metabolites in the development of peripheral insulin resistance and type 2 diabetes pathogenesis. DGK␦ deficiency also influences skeletal muscle energetics, which may lead to low physical activity levels in type 2 diabetes. lipid oxidation; skeletal muscle; diacylglycerol kinase; AMPK; contraction DIACYLGLYCEROL (DAG) KINASES (DGK) are a family of lipid kinases that catalyze the phosphorylation and conversion of DAG into phosphatidic acid (PA). Elevated DAG content is linked with the development of insulin resistance in type 2 diabetes (27, 36). Thus, modulating the level of distinct DGK isoforms may influence the level of DAG and consequently insulin sensitivity.
duced in skeletal muscle from type 2 diabetic patients and diabetic rodents and normalized upon correction of hyperglycemia (11) . Given that DAG is a precursor for triglyceride biosynthesis, DGKs are potentially involved in regulating fat deposition. Indeed, DGK␦ haploinsufficient (DGK␦ ϩ/Ϫ ) mice develop obesity later in life (11) , and knockdown of DGK␦ markedly suppresses triglyceride (TG) synthesis in 3T3-L1 preadipocytes (28) . Yet, the mechanism by which DGK␦ affects lipid synthesis and other aspects of lipid metabolism remains unclear.
AMP-activated protein kinase (AMPK) is a central regulator of energy metabolism. AMPK is heterotrimeric complex composed of a catalytic ␣-subunit and regulatory ␤-and ␥-subunits. Phosphorylation on the Thr 172 residue of ␣-subunit by liver kinase B (LKB1) (20) or calmodulin-dependent protein kinase kinase (CaMKK) (18, 19) is required for AMPK activation. Conversely, phosphorylation of the ␣-subunit on Ser 485/491 by protein kinase A (15) , protein kinase B (21) , and protein kinase C (PKC) (12) blocks AMPK activation. Nutrient excess in type 2 diabetes or obesity elevates DAG levels and PKC activity and impairs insulin sensitivity (34) . While AMPK activation reverses many diabetes-associated metabolic defects, AMPK activity is decreased in multiple tissues from insulin-resistant and obese animal models (35) . Whether excessive DAG levels further impair AMPK signaling and contribute to diabetesassociated metabolic impairments is unknown.
In addition to AMPK signaling defects (34) , impairments in lipid oxidation (4, 24) are also involved in the pathogenesis of obesity and type 2 diabetes. AMPK controls lipid metabolism through acetyl-CoA carboxylase (ACC) and malonyl-CoA decarboxylase (MCD) (33, 41) . ACC has two isoforms (ACC␣/ ␤), and ACC␤ is the dominant isoform expressed in skeletal muscle (39) . Of the phosphorylation sites on ACC, Ser 79 is the major site responsible for the inhibition of ACC activity, whereas Ser 219/221 is associated with muscle contraction-induced fatty acid oxidation (39) . ACC produces and MCD degrades malonyl-CoA, a factor which functions both as substrate for de novo fatty acid synthesis and as inhibitor of the fatty acid transporter carnitine palmitoyltransferase-1 (CPT-1) at the mitochondrial membrane (44) . Whether DGK␦ is coupled to AMPK activation and lipid metabolism remains unclear.
Here, we determined the effects of physical and chemical AMPK agonists to unravel the role of DGK␦ in AMPK-related signal transduction and lipid metabolism. Whereas complete loss of DGK␦ is lethal due to respiratory dysfunction (13) , DGK␦ ϩ/Ϫ mice are viable but develop obesity and skeletal muscle insulin resistance with age (11) . We found that DGK␦ ϩ/Ϫ mice have reduced physical activity and increased muscle fatigue, implying a role in skeletal muscle energetics. Furthermore, lipid storage is favored over lipid oxidation, concomitant with reduced AMPK activity in skeletal muscle. Thus, reduced DGK␦ impairs AMPK signaling and muscle function presumably via altering DAG content.
RESEARCH DESIGN AND METHODS
DGK␦ haploinsufficient mice. The method used to generate haploinsufficient DGK␦ (DGK␦ ϩ/Ϫ ) mice (13) and data regarding glucose and energy homeostasis have been reported (11) . DGK␦ mRNA expression, protein content, and kinase activity are reduced in DGK␦ ϩ/Ϫ mice (11). We (29) have previously reported that mRNA expression of DGK␦ is similar between EDL and soleus muscle. Five month-old male DGK␦ ϩ/Ϫ mice and wild-type littermates were housed in a temperature-controlled 12:12-h light-dark environment and fed standard rodent chow and water ad libitum. Mice were fasted for 4 h and anesthetized with Avertin (2,2,2-tribromoethanol 99% and tertiary amyl alcohol, 1:1 wt/vol, 500 mg/kg) via intraperitoneal injection prior to all terminal experiments. The Regional Animal Ethics Committee (Stockholm, Sweden) approved the experimental procedures.
Voluntary exercise training protocol. Mice were housed for 4 wk in individual cages equipped with a running wheel. Running activity (wheel revolutions) was automatically recorded using VitalView Animal Monitoring software (Mini Mitter, Bend, OR). The average number of wheel revolutions per hour from days 2-4 of the voluntary exercise training protocol was analyzed.
Locomotor activity. Locomotor activity was measured before and after 4 wk of voluntary wheel running, as described (36) . Mice were housed in individual Plexiglas cages of the Comprehensive Lab Animal Monitoring System (CLAMS; Columbus Instruments, Columbus, OH), and locomotor activity was continuously monitored. During the CLAMS session, mice were maintained on a 12:12-h light-dark cycle and had free access to standard rodent chow and water.
Glycogen content. Gastrocnemius muscle was removed from untrained anesthetized 5-mo-old male DGK␦ ϩ/Ϫ mice and wild-type littermates. Muscles were cleaned of fat and blood and frozen in liquid nitrogen. Glycogen content was determined fluorometrically on HCl extracts (2) .
Skeletal muscle incubation and glucose transport. Incubation medium was prepared from a stock solution of pregassed (95% O 2-5% CO 2) Krebs-Henseleit bicarbonate buffer (KHB) supplemented with 5 mM HEPES and 0.1% bovine serum albumin (BSA, RIA grade). Extensor digitorum longus (EDL) and soleus muscles were preincubated for 30 min in KHB supplemented with 5 mM glucose and 15 mM mannitol and incubated in the absence or presence of 2 mM 5-aminoimidazole-4-carboxamide-1-␤-D-ribofuranoside (AICAR). Muscles were rinsed in glucose-free KHB containing 20 mM mannitol and transferred to KHB supplemented with 19 mM mannitol, 1 mM 2-deoxy-D-glucose, 2.5 Ci/ml 2-deoxy-D- [ 3 H]glucose (American Radiolabeled Chemicals) and 0.7 Ci/ml [ 14 C]mannitol (Moravek Biochemicals) and incubated in the absence or presence of AICAR for 20 min. All incubations were performed in individual vials placed in a shaking water bath (30°C) with a constant gas phase (95%O 2-5%CO 2).
Glucose oxidation and glucose incorporation into glycogen. The method was adapted from Ref. 1 . Skeletal muscle was incubated at 30°C for 60 min in 2 ml of KHB supplemented with 5 mM [U-14 C]glucose (0.3 Ci/ml) in a sealed flask that contained a center well. After incubation, the muscle sample was quickly removed for biochemical analysis, and the flask was resealed. Thereafter, 200 l of protosol was injected into the center well, and 500 l of 15% PCA was injected into the medium. The flask was incubated for 60 min, and liberated CO 2 was collected into the protosol to assess glucose oxidation. The muscle was dissolved with 0.5 ml of 1 M NaOH at 70°C for 30 min to assess glucose incorporation into glycogen. After TCA deproteinization, glycogen was sedimented from the skeletal muscle lysate by adding 95% ethanol and dissolved in 200 l of 1 M NaOH. The 14 C collected in the protosol and glycogen was measured by liquid scintillation counting.
In vitro muscle contraction. In vitro contractions were performed as described (3) . Paired EDL muscles were placed in contraction chambers (Multi Myograph System; Danish Myo Technology, Aarhus, Denmark) containing KHB supplemented with 5 mM glucose, 15 mM mannitol, 0.3 mM palmitate, and 4% fatty acid-free BSA and incubated for 30 min (3). Thereafter, the contraction chambers were emptied and refilled with the same medium containing 4 Ci/ml [9,10(n)- 3 H] palmitic acid (GE Healthcare). One muscle was incubated under resting conditions, while the contralateral muscle was subjected to a contraction protocol consisting of a 5-min contraction session followed by a 5-min resting session that was repeated for six cycles. During the contraction sessions, the isolated skeletal muscle was stimulated with 0.1-ms 25 Hz pulses for 0.3 s (3). Muscles were frozen in liquid nitrogen, and medium was analyzed for tritiated water (9) . Raw data were extracted from LabChart files containing recordings of the contraction experiments, and average trains were created in Python software (http://www.python.org). Baseline and area under the curve were calculated in R software (http://www.r-project.org).
Palmitate oxidation and incorporation into intramuscular lipids. EDL and soleus muscles were preincubated for 20 min in KHB containing 5 mM glucose, 15 mM mannitol and 4% fatty acid free BSA. Muscles were transferred to vials containing fresh medium supplemented with 300 M of cold palmitate with 4 Ci/ml [9,10(n)-3 H]palmitic acid for assessment of palmitate oxidation, or 2 Ci/ml [U- 14 C]palmitic acid (PerkinElmer) for assessment of palmitate incorporation into intramuscular lipids. Muscles were incubated for 2 h in the absence or presence of 2 mM AICAR. Muscles were immediately frozen in liquid nitrogen. Palmitate oxidation was quantified by measuring tritiated water (9) . The amount of palmitate metabolized into intramuscular lipids was determined (30) . Intramuscular lipids were extracted in isopropanol-hexane-KCl (2:4:1). The lipid pellet was suspended in 50 l of chloroform-methanol (1:1), spotted on thin-layer chromatography (TLC) plates (Whatman), and separated in a hexane-diethylether-acetic acid (80:20:3) system. 1,2-Dioctanyl- [ Quantitation of malonyl-CoA and acetyl-CoA content. MalonylCoA and acetyl-CoA content was determined in skeletal muscle (5) . Snap-frozen muscle samples (ϳ10 mg) were collected in 2-ml homogenization tubes and stored at Ϫ80°C. Samples underwent simultaneous and automated tissue homogenization and analyte extraction in methanolic trifluoroacetic acid, performed at Ϫ20°C in the presence of BSA and an internal standard. Sample purification was achieved by a simple lipid extraction step using chloroform. After evaporation of the aqueous extract to dryness, analytes were dissolved in injection solvent to remove the trifluoroacetic acid. Samples were subsequently separated by ion-pair HPLC based on a di-isopropyl-ethylamineammonium acetate buffer in water-acetonitrile and a Hypersil GOLD reversed-phase C18 column with high pH stability. Malonyl-CoA and acetyl-CoA levels were determined quantitatively by negative electrospray tandem mass spectrometry using an Ultima PT mass spectrometer (Micromass UK). The detection limit was Ͻ1 pmol. Calibration and quality control samples were included in each run.
AMPK activity. AMPK activity was determined as described (14) . AMPK was immunoprecipitated from EDL and soleus muscle lysates (300 g) using antibodies against AMPK␣1 and -␣2 (Prof. D. G. Hardie) and incubated for 30 min (30°C) in a total volume of 30 l, 32 P]ATP. The reaction was terminated by spotting 25 l of the mixture onto P81 filter paper and washing four times for 15 min in 1% phosphoric acid. The dried filter paper was analyzed by liquid scintillation.
Western blot. Muscles were homogenized in ice-cold buffer (10% glycerol, 5 mM sodium pyrophosphate, 137 mM NaCl, 2.7 mM KCl, 1 mM MgCl 2, 20 mM Tris, pH 7.8, 1% Triton X-100, 10 mM sodium fluoride, 1 mM EDTA, 0.2 mM phenylmethylsulfonyl fluoride, 1 g/ml aprotinin, 1 g/ml leupeptin, 0.5 mM sodium vanadate, 1 mM benzamidine, 1 M microcystin). Homogenates were rotated end over end for 1 h at 4°C and subjected to centrifugation (12,000 g for 10 min) at 4°C. Protein content in the supernatant was evaluated using a commercially available kit (Pierce, Thermo Fisher Scientific). An equal amount of protein (30 g) was subjected to Western blot analysis as described (11) . Protein phosphorylation and abundance were determined using the following antibodies: phospho-AMPK␣ (Santa Cruz Biotechnology). GAPDH was used to confirm equal protein loading. Proteins were visualized by enhanced chemiluminescence (ECL; GE Healthcare) and quantified by densitometry using Quantity One Software (Bio-Rad).
Quantitative real-time PCR. Total RNA was purified from tibialis anterior muscle using TRIzol reagent (Invitrogen) and treated with DNase I (DNA-free kit, Ambion). cDNA synthesis was performed using the SuperScript First Strand Synthesis System (Invitrogen) and random hexamer primers. PCR was assessed in a final volume of 25 l, consisting of diluted cDNA sample, 1ϫ SYBR Green PCR Master Mix (Applied Biosystems), gene-specific primers, and nuclease-free water. CPT-1 mRNA was assessed using quantitative RT-PCR (ABI PRISM 7000 Sequence Detector System, Applied Biosystems). All samples were analyzed in duplicate. Relative quantities of CPT-1 were calculated after normalization by a reference gene (36B4, also known as RPLP0) using the ⌬C T method (Applied Biosystems).
Statistical analysis. Results are expressed as means Ϯ SE. Statistical analysis for voluntary wheel running activity was performed with general linear model and repeated measures using the Statistical Package for the Social Sciences (SPSS). Other statistical analyses were performed using two-way ANOVA followed by Bonferroni post hoc test or Student's t-test when appropriate (Graph Prism v. 5.0). Results were considered statistically significant at P Ͻ 0.05.
RESULTS

Locomotor activity is reduced in DGK␦
ϩ/Ϫ mice. DGK␦ ϩ/Ϫ mice and wild-type littermates were housed individually for 4 wk with unlimited access to running wheels. Locomotor activity was measured before and after 4 wk of voluntary wheel running. Locomotor activity was reduced in DGK␦ ϩ/Ϫ mice before, but not after the 4 wk of voluntary wheel running ( Fig. 1, A and B) . DGK␦ ϩ/Ϫ mice ran fewer cycles than wild-type mice during the 12-h dark period at the onset of training ( Fig. 1C ; average of days 1-3, P Ͻ 0.05). These findings indicate that DGK␦ deficiency may alter skeletal muscle energetics. However, after 1 wk, DGK␦ ϩ/Ϫ and wildtype mice performed the same amount of daily exercise (Fig.  1D , average of days 8 -10) . To ascertain whether this difference in locomotor activity at the onset of training was reflected by alterations in fuel selection or availability, muscle glycogen content was measured. Intramuscular glycogen levels were similar between untrained wild-type and DGK␦ ϩ/Ϫ mice (Fig. 1E) . Proteins related to mitochondrial function are unaltered by DGK␦ deficiency. Skeletal muscle abundance of sirtuin 1 (SIRT1), an NAD-dependent deacetylase important for the regulation of mitochondrial biogenesis, as well as several mitochondrial proteins, including succinate dehydrogenase (SUO), pyruvate dehydrogenase kinase isoenzyme 4 (PDK4), ATP synthase, and cytochrome c oxidase subunit 1 (COX1), was unaltered between DGK␦ ϩ/Ϫ and wild-type mice ( Fig. 2A) . Furthermore, CPT-1 mRNA was unaltered between DGK␦ ϩ/Ϫ and wild-type mice (Fig. 2B) . Collectively, these results provide evidence to suggest that the reduction in voluntary physical activity in DGK␦ ϩ/Ϫ mice is not associated with altered mitochondria protein abundance.
AMPK activation is attenuated in skeletal muscle from DGK␦ ϩ/Ϫ mice. To test whether the reduced voluntary wheel running in DGK␦ ϩ/Ϫ mice is related to alterations in energy sensing, EDL muscles were incubated in the absence or presence of the AMPK agonist (AICAR), and signal transduction was assessed. AICAR-induced AMPK␣1 and AMPK␣2 activity was abolished in skeletal muscle from DGK␦ ϩ/Ϫ mice (Fig. 3, A and B) . Moreover, AMPK Thr 172 phosphorylation was decreased (Fig. 3C) and AMPK inhibitory Ser 485/491 phosphorylation was increased (Fig. 3D ) in AICAR-treated skeletal muscle from DGK␦ ϩ/Ϫ mice. DGK␦ deficiency did not alter protein abundance of AMPK␣1 and AMPK␣2 subunits (Fig. 3, E and F) . Protein abundance of LKB1, an upstream regulator of AMPK, was unaltered between wild-type and DGK␦ϩ/Ϫ mice (0.83 Ϯ 0.09 vs. 0.88 Ϯ 0.10 mean Ϯ SE arbitrary units, respectively). Strikingly, we found that AICAR-induced ACC phosphorylation at Ser 79 ( Fig. 3G) and Ser 219/221 (Fig. 3H) was unaltered between genotypes. Phosphorylation of AS160 (Fig. 3I ) and TSC2 (Fig.  3J) , other AMPK targets, was not increased by AICAR stimulation and was unaltered by DGK␦ deficiency.
Effect of DGK deficiency on AICAR-induced malonyl-CoA and acetyl-CoA levels. Malonyl-CoA is an allosteric inhibitor of CPT, the enzyme that controls the transfer of long-chain fatty acyl CoA molecules into mitochondria where they are oxidized. We found a trend for reduced malonyl-CoA levels in AICAR-treated EDL muscle from wild-type (P ϭ 0.11) but not DGK␦ ϩ/Ϫ mice (Fig. 4A) . Basal acetyl-CoA levels tended to be reduced in DGK␦ ϩ/Ϫ mice (Fig. 4B) ; however, AICAR-stimulated levels were similar between genotypes. 
DGK deficiency alters AMPK-induced lipid metabolism in skeletal muscle.
We next examined whether the diminution in AICAR-mediated AMPK signaling in DGK␦ ϩ/Ϫ mice is associated with impaired lipid metabolism. Palmitate oxidation was measured in EDL ( Fig. 5A ) and soleus ( Fig. 5B ) muscle incubated in the absence or presence of AICAR. AICARstimulated palmitate oxidation was reduced in EDL and soleus muscle from DGK␦ ϩ/Ϫ vs. wild-type mice (Fig. 5, A and B) . To determine the fate of lipid species, EDL muscle was incubated with [ 14 C]palmitate, and subsequently intramuscular TG, fatty acids, and DAG were separated by TLC (Fig. 5C) . Quantification of these lipid species under basal and AICARstimulated conditions reveals that a greater amount of [ 14 C]palmitate was incorporated into TG in EDL muscle from DGK␦ ϩ/Ϫ mice (Fig. 5D ). Palmitate incorporation into TG in soleus muscle was not altered by either AICAR treatment or DGK␦ haploinsufficiency (Fig. 5E ). The increase of [ 14 C]palmitate incorporation into DAG did not reach statistical significance (quantification not shown); however, we (11) have previously reported that total DAG content is increased in this model. Thus, DGK␦ deficiency may shift the balance of lipid metabolism by reducing fatty acid oxidation and increasing intramuscular lipid storage.
AICAR-stimulated glucose metabolism is unchanged in DGK␦ ϩ/Ϫ mice. To investigate whether DGK␦ haploinsufficiency affects AMPK-mediated glucose metabolism, glucose uptake (Fig. 6, A and B) , glucose oxidation (Fig. 6, C and D) , and glucose incorporation into glycogen (Fig. 6, E and F) were measured in EDL and soleus muscle in vitro. In EDL, but not in soleus, AICAR-stimulated glucose metabolism was increased compared with baseline in wild-type and DGK␦ ϩ/Ϫ mice (Fig. 6, A-F) . Rates of basal and AICAR-stimulated glucose uptake, glucose oxidation, and glucose incorporation into glycogen were similar between wild-type and DGK␦ ϩ/Ϫ mice (Fig. 6, A-F) . Thus, DGK deficiency selectively impairs AMPK signal transduction on lipid, but not glucose metabolism.
DGK␦ deficiency impairs contraction-induced lipid oxidation and signal transduction.
Since AICAR-stimulated AMPK activation and fatty acid oxidation were attenuated in DGK␦ ϩ/Ϫ mice, we explored the response of other modes of AMPK activation that disturb energy homeostasis. Electrically stimulated contraction increased (15%) palmitate oxidation in EDL muscle from WT mice (Fig. 7A) but not in DGK␦ ϩ/Ϫ mice. To investigate whether the abundance of DGK␦ influ- ences contraction-induced signaling events, phosphorylation of AMPK and ACC was measured in EDL muscle given their involvement in lipid oxidation. While basal and contractioninduced AMPK Thr172 phosphorylation was not influenced by DGK␦ deficiency (Fig. 7B) , an overall reduction in ACC phosphorylation was observed in DGK␦ ϩ/Ϫ mice (Fig. 7C) . These results further support a role for DGK␦ in lipid metabolism in response to energy stress.
DGK␦ abundance influences muscle force generation.
To investigate whether the reduction in contraction-induced fatty acid oxidation in DGK␦ ϩ/Ϫ mice is associated with altered skeletal muscle energetics, we determined force generation during in vitro contraction (Fig. 8A ). Baseline muscle tension was similar between wild-type and DGK␦ ϩ/Ϫ mice at the start of the first contraction interval (Fig. 8, B and C) and was transiently increased in both strains after five contraction ses- sions. Yet, the increase in baseline muscle tension with each contraction interval was markedly greater in DGK␦ ϩ/Ϫ mice than in wild-type mice (P Ͻ 0.05; Fig. 8, B and C) . Baseline muscle tension prior to the start of the sixth and final contraction interval was 2.6-fold higher in DGK␦ ϩ/Ϫ mice (Fig. 8D) . However, net force generation, calculated as area under curve for each interval, was similar between wild-type and DGK␦ ϩ/Ϫ mice (Fig. 8E ). This alteration in tension release indicates that DGK␦-deficient muscle is more prone to fatigue, possibly due to limited energy supply, as the transport of calcium into sarcoplasmic reticulum depends on the hydrolysis of ATP.
DISCUSSION
Dysregulation of AMPK signaling, arising from nutrient excess and elevated glucose and lipid levels in obesity and type 2 diabetes, has been linked to the development of insulin resistance (34) . Nutrient excess decreases AMPK activity, concomitant with increased DAG content (12) , highlighting a deleterious role for specific lipid metabolites such as DAGs and ceramides in the development of peripheral insulin resistance (27, 36 ). Here, we tested the hypothesis that the abundance of DGK␦ is of relevance for maintaining appropriate AMPK action since they catalyze a reaction that removes DAG and thereby terminate PKC signaling and may subsequently influence AMPK signaling. The central findings of this study are that physical activity and skeletal muscle energetics are impaired in DGK␦ ϩ/Ϫ mice. Furthermore, lipid storage is favored over lipid oxidation, concomitant with reduced AMPK activity. AICAR-induced AMPK Thr 172 phosphorylation was attenuated, whereas AMPK inhibitory Ser 485/491 phosphorylation was increased. Thus, we provide evidence for a link between DGK␦ and AMPK signaling. Reduced DGK␦ impairs AMPK signaling and skeletal muscle function presumably via altering intramuscular DAG content and AMPK Ser 485/491 phosphorylation.
The precise mechanism by which DGK␦ haploinsufficiency suppresses AMPK activity remains unclear. However, AICARinduced AMPK Thr 172 phosphorylation is reduced and AMPK inhibitory Ser 485/491 phosphorylation is increased in DGK␦ ϩ/Ϫ mice. Furthermore, we have previously reported that total DAG content is increased concomitant with PKC activation in DGK␦ ϩ/Ϫ mice (11) . PKC activation has been proposed as one mechanism for the inhibitory phosphorylation of AMPK Ser 485/491 (12) . Thus, excessive PKC activation concomitant with AMPK-inhibitory Ser 485/491 phosphorylation may mechanistically suppress AMPK activity in the DGK␦ ϩ/Ϫ mice (Fig. 9) . Here, we report that DGK␦ ϩ/Ϫ mice preferentially favor lipid storage over oxidation. Indeed, we note elevated levels of intramuscular DAG (11), a precursor of triglycerides in skeletal muscle from DGK␦ ϩ/Ϫ mice. The TG pool can then be hydrolyzed to long-chain fatty acid CoA (LCFACoA) and act as a substrate for ceramide generation. Increased ceramide content is associated with activated protein phosphatase 2A (PP2A), dephosphorylation of AMPK Thr 172 , and decreased AMPK activity (45) . Thus, elevated PKC or PP2A may suppress AMPK activity (Fig. 9) .
DGK␦ expression and DGK activity are reduced in skeletal muscle from type 2 diabetic patients, concomitant with elevated DAG content (11) . Moreover, DGK␦ haploinsufficiency increased DAG content, impaired peripheral insulin signaling, and glucose transport and led to age-dependent obesity. Metabolic flexibility, evident by the transition between lipid and carbohydrate utilization during fasted and fed conditions, was also impaired in DGK␦ ϩ/Ϫ mice (11). Thus, DGK␦ deficiency causes peripheral insulin resistance and metabolic inflexibility and contributes to mild obesity in later life. In this study, we demonstrated that DGK␦ ϩ/Ϫ mice exhibit reduced AMPK activity and related signal transduction in skeletal muscle, in parallel with a shift toward enhanced incorporation of fatty acid into neutral lipid storage and diminished fatty acid oxidation. Partial degradation of fatty acids due to incomplete fatty acid oxidation can contribute to the development of lipidinduced insulin resistance (26) . Nevertheless, the abundance of several mitochondrial proteins and regulators of mitochondrial biogenesis was unchanged. In cultured preadipocytes, DGK␦ silencing caused a concomitant decrease of DAG, PA, and triglycerides (28) . DGK overexpression in preadipocytes promotes lipogenesis (37) , consistent with a role for DGK in lipid storage in fat cells. Skeletal muscle contains substantially less total lipid than adipocytes, so the pool of DAG and PA regulated by DGK␦ may comprise a major portion of total lipid available for storage and oxidation. Thus, the reduction in lipid oxidation in skeletal muscle from DGK␦ ϩ/Ϫ mice might be secondary to the increase in lipid storage.
We observed that AICAR-induced AMPK Thr 172 phosphorylation was decreased and AMPK inhibitory Ser 485/491 phosphorylation was increased in DGK␦ ϩ/Ϫ mice, concomitant with impaired lipid oxidation. Nevertheless, AICAR-induced glucose uptake was intact, consistent with previous observations that AICAR increases glucose uptake in skeletal muscle from severely insulin-resistant rodents and type 2 diabetic patients (25, 38) . Basal and AICAR-induced glucose oxidation and glucose incorporation into glycogen were also unaltered in skeletal muscle from DGK␦ ϩ/Ϫ mice. Thus, DGK␦ deficiency leads to selective AMPK resistance on lipid, but not glucose, metabolism. Although the precise mechanism for the selective AMPK resistance on lipid versus glucose metabolism is unclear, DAG levels are constitutively elevated in DGK␦ ϩ/Ϫ mice (11) , and this may have a persistent effect to restrain lipid oxidation. Here, we report that palmitate incorporation into triglycerides is increased in DGK␦ ϩ/Ϫ mice, suggesting a protective mechanism may limit the accumulation of lipid intermediates such as DAG. For example, in high-fat-fed mice, overexpression of a constitutively active mutant form of AMPK in skeletal muscle reduces DAG levels and restores lipid oxidation (2) . Thus, the level of specific lipid metabolites may influence the efficacy of AMPK activators in promoting lipid oxidation. However, additional studies are warranted to elucidate the relationship between the accumulation of lipid intermediates and AMPK activity and to understand the impact these lipid metabolites on fatty acid oxidation and metabolism.
AMPK phosphorylates and inhibits ACC, which reduces malonyl-CoA, an inhibitor of CPT-1, the enzyme controlling transfer of lipids into the mitochondria for ␤-oxidation (33). We found that AICAR stimulation tended to reduce malonylCoA levels in skeletal muscle from wild-type but not AMPKresistant DGK␦ ϩ/Ϫ mice. Thus, DGK␦ ϩ/Ϫ mice are resistant to the action of AICAR to reduce malonyl-CoA levels and relieve the inhibition of CPT-1 on lipid oxidation. Unexpectedly, ACC phosphorylation was preserved in DGK␦ ϩ/Ϫ mice despite diminished AICAR-stimulated AMPK activation. Notably, phosphorylation of other direct substrates of AMPK, AS160 and TSC2, were unaltered in DGK␦ ϩ/Ϫ mice. However, given the lack of AICAR-induced AMPK activation and lipid oxidation in DGK␦ ϩ/Ϫ mice, our finding that malonyl-CoA levels were unaltered by AICAR stimulation in DGK␦ ϩ/Ϫ mice was unsurprising and may provide a mechanism for the alteration in lipid fuel partitioning. Indeed, we found a reciprocal relationship between fatty acid synthesis and lipid oxidation in DGK␦ ϩ/Ϫ mice. We also found that LKB1 and AMPK isoform abundance was unaltered in DGK␦ ϩ/Ϫ mice. Thus, our finding of impaired AICAR-induced AMPK phosphorylation, but normal ACC and other AMPK targets of phosphorylation and acetyl-CoA content is consistent with the notion of redundant signaling, such that one or more kinases other than AMPK may impinge upon ACC (40) . (an inhibitory site). DAG excess will be stored as TG. The TG pool can then be hydrolyzed to long-chain fatty acid CoA (LCFACoA) and act as a substrate for ceramides generation. Increase in ceramide levels activate the protein phosphatase 2A (PP2A), which dephosphorylates AMPK on Thr 172 , leading to suppression of AMPK activity. PA, phosphatidic acid. Some notable differences in AICAR-and contraction-induced signaling and metabolism were observed in DGK␦ ϩ/Ϫ mice. Under AICAR-stimulated conditions, AMPK phosphorylation and activity were severely blunted, but ACC phosphorylation was robustly increased in DGK␦ ϩ/Ϫ mice. Yet, in response to muscle contraction, AMPK activity was similarly increased between wild-type and DGK␦ ϩ/Ϫ mice, but ACC phosphorylation was attenuated in DGK␦ ϩ/Ϫ mice. This apparent disparity does not necessarily suggest that AMPK is dispensable for ACC activity; rather, our findings may reflect differential sensitivity to the integration of signals mediated via AMPK from diverse stimuli. For example, in response to electrically stimulated muscle contraction, ACC phosphorylation is detectable prior to measurable increases in AMPK activity (22) . In humans, low-intensity exercise induces a profound increase of ACC phosphorylation with only a modest increase in AMPK phosphorylation (10) . Furthermore, intravenous administration of AICAR in type 2 diabetic patients increases skeletal muscle ACC phosphorylation without any measurable change of AMPK phosphorylation (6) . Thus, differences in the sensitivity of AMPK and ACC to the various stimuli, the time course of activation, or the involvement of other protein kinases may explain the divergent response of wild-type and DGK␦ ϩ/Ϫ mice between AICAR-or contraction-stimulated conditions.
Exercise capacity is often reduced in people with obesity or type 2 diabetes due to lack of physical activity (7, 46) . Strikingly, we found that DGK␦ deficiency impairs overall work performance, as evident by reduced voluntary activity, and impaired skeletal muscle energetics, as evident by altered force production and relaxation in response to repeated contractions. Contrasting AMPK deficient "lazy" mouse models, skeletal muscle glycogen content was unaltered in DGK␦ ϩ/Ϫ mice. Impaired lipid metabolism in the DGK␦ ϩ/Ϫ mice may account for the reduced physical activity, since low-to moderate-intensity endurance exercise relies on lipid oxidation (8) . Moreover, the reduction in voluntary running activity of untrained DGK␦ ϩ/Ϫ mice occurred in parallel with a reduction of AICAR-or contraction-induced lipid oxidation, which is likely due to intrinsic changes in skeletal muscle, consistent with earlier studies of AMPK-deficient mouse models (1, 32) . Interestingly, voluntary activity of DGK␦ ϩ/Ϫ mice was normalized after 10 days of wheel running, which may reflect skeletal muscle remodeling and other exercise training-induced adaptations.
Following repeated contractions, resting tension was higher in skeletal muscle from DGK␦ ϩ/Ϫ mice. In the absence of muscle fatigue, this rapid relaxation process is mediated by calcium efflux from the cytosol, which depends on the intact function of sarco/endoplasmic reticulum calcium ATPase (SERCA) (43) . SERCA expression in DGK␦ ϩ/Ϫ mice was unaltered (data not shown). However, as an active transporter of calcium, SERCA requires the hydrolysis of ATP to supply energy. Since AMPK-induced lipid oxidation was impaired in DGK␦ ϩ/Ϫ mice, we hypothesize that the restricted energy supply during muscle contraction might influence force production and relaxation. Phosphatidylethanolamine (PE) is a component of the lipid bilayer of the sarcoplasmic reticulum that promotes calcium binding to SERCA (17) . PA, which is the product of DGK, is also the substrate for phosphatidylethanolamine biosynthesis (23) . Thus, DGK haploinsufficiency may decreases SERCA activity by reducing PE levels. Indeed, muscle-specific ablation of fatty acid synthase causes muscle weakness by reducing PE content and SERCA activity in sarcoplasmic reticulum (16) . Whether insufficient energy supply or reduced SERCA activity causes functional defects in skeletal muscle from DGK␦ ϩ/Ϫ mice remains to be determined.
In conclusion, DGK␦ abundance influences physical activity and muscle fatigue, implying a possible role in skeletal muscle bioenergetics. Collectively, our results imply a role for DGK␦ in the regulation of lipid oxidation and storage via AMPK signaling pathways. Reduced DGK␦ impairs AMPK signaling and muscle function presumably via altering intramuscular DAG content. Our results suggest that efforts to pharmacologically modulate the abundance or activity of DGK␦ may reveal new treatment opportunities for metabolic disorders.
